CompoAtlas

HARPAGOPHYTON FORTE 1450 MG

Food supplement declared in France, declaration No 2018-4-1096, decision dated 25 April 2018

HARPAGOPHYTON FORTE 1450 MG (RELAFIT) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Harpagophytum procumbens 247 mg per day, Harpagophytum procumbens 215 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
RELAFIT
Food business operator placing the product on the market
LABORATORIOS MORALES SOLER, S.L.
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
1 CAPSULE
Directions for use
PRENDRE 1 CAPSULE PAR JOUR
Not recommended (according to the manufacturer)
Ulcer (stomach or duodenum)

Declaration 262355, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Harpagophytum procumbensRacineExtrait sec aqueux247 mg
Harpagophytum procumbensRacinePoudre (de plantes séchées ou broyées)215 mg

Additives

E470b

Other ingredients

gélatine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

VOIR ETIQUETAGE POUR VOIR LES AVERTISSEMENTS

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Harpagophytum procumbens
    Read the warning, when it applies and the studies cited

    DEVIL'S CLAW - HARPAGOPHYTUM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 27 March 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : RELAFIT

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “HARPAGOPHYTON FORTE 1450 MG (RELAFIT): composition and regulation”, https://compoatlas.com/en/supplements/products/262355-harpagophyton-forte-1450-mg, updated 15 November 2026.

List recorded in 2018. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line